Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients. [electronic resource]
Producer: 20090427Description: 292-300 p. digitalISSN:- 1600-0609
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Chromosomes, Human, Pair 22
- Chromosomes, Human, Pair 9
- Drug Resistance, Neoplasm
- Female
- Fusion Proteins, bcr-abl -- drug effects
- Gene Amplification
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Rearrangement
- Humans
- Imatinib Mesylate
- In Situ Hybridization, Fluorescence
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Piperazines -- therapeutic use
- Polymerase Chain Reaction
- Pyrimidines -- therapeutic use
- Reverse Transcriptase Polymerase Chain Reaction
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.